Aplastic Anemia and Myelodysplastic Syndromes (MDS)
Why choose us for aplastic anemia and MDS care?
Aplastic anemia and myelodysplastic syndromes (MDS) are rare, complicated bone marrow disorders that can become cancerous. Doctors at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, have the expertise for precise diagnosis and care.
These conditions have similarities, including symptoms that mirror those of other blood conditions. Each requires a specific treatment approach. Our fellowship-trained blood cancer specialists (hematologist oncologists) perform a careful evaluation, including sophisticated testing.
We offer leading-edge treatments, such as immunotherapy. Patients with inherited disorders receive coordinated care from pediatric and adult hematologist oncologists.
Aplastic anemia and MDS are some of the many blood disorders we treat. Learn more about our blood disorder (hematology) program.
What you need to know about aplastic anemia and myelodysplastic syndromes
- Your bone marrow produces stem cells. Your body relies on stem cells to produce blood components, including platelets and white and red blood cells. With aplastic anemia and myelodysplastic syndromes, the bone marrow produces abnormal stem cells.
- Aplastic anemia is passed down in families. It is often diagnosed in childhood or early adulthood. MDS typically occurs in older adults. It can become blood cancer, specifically acute myeloid leukemia.
- Some people with aplastic anemia or MDS have more than one rare bone marrow disorder. They may develop rare blood problems such as paroxysmal nocturnal hemoglobinuria, where red blood cells break apart.
- You may need inpatient services, including a bone marrow transplant. We coordinate those services with hospital-based physicians. Clinic-based (outpatient) services are available at Mays Cancer Center.
Close
